Treatment Decision-Making for HR-MDS Patients
Getting a High-Risk MDS diagnosis can be overwhelming. Dr. Taylor joins us to talk about HR-MDS, what kinds of treatment decisions patients have to make, and what can help inform those decisions.
Mary introduces the agenda for the event and featured speaker Dr. Justin Taylor.
Dr. Justin Taylor will present on decision making for HR-MDS patients.
Type your questions in the chat and Dr. Taylor will answer them!
Mary Arnett
Mary joined HealthTree as the HealthTree for MDS Program Manager in 2022. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for MDS patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.
Justin Taylor
Justin Taylor, MD, is a physician-scientist devoted to improving outcomes for patients with hematologic malignancies. The Taylor lab studies the role of recurrent mutations in hematologic malignancies and how to target them with novel therapeutics using animal modeling, molecular biology, and single-cell genomic techniques. Dr. Taylor holds a faculty position in the Department of Medicine, Division of Hematology where he sees patients with hematologic malignancies. He is the principal investigator on grants sponsored by the National Cancer Institute (K08), American Society of Hematology, the Robert Wood Johnson Foundation and the Edward P. Evans Foundation for MDS. He has received Young Investigator Awards from ASCO Conquer Cancer Foundation, Hairy Cell Leukemia Foundation, and Evans MDS Foundation.